BLOG
Blog
Choosing the Best Bioanalytical Platform for Your Program
Altasciences’ experts take time to fully understand all aspects of your program, and with their knowledge of the various bioanalytical platforms, recommend the most effective solution.
Blog
Miniature Swine: Changing the Bias for Nonclinical Studies on Small Molecules and Biologics
Miniature swine have distinct advantages in safety assessment studies, beyond dermal. Click here to read more.
Blog
Top 10 Life Science Resources - July 2023
Discover some of the expert insights, tips, case studies, and more that you may have missed from us!
Blog
Cancer Treatments, Clinical Trials, and the Motivation to Innovate
"I am alive because of a clinical trial, and if I can help facilitate more of them, and if I can help make the experience less extreme, that’s a big deal for me."
Blog
Top 5 Ways Integrated Drug Development Solutions Save You Time and Money
Discover the top five ways an integrated drug development pathway can save you time and money, while giving your program the best chance at success.
Blog
Drug Development Timelines: How Health Canada’s 30-Day Regulatory Review Process Could Provide an Advantage
The EMA recently updated their clinical trial application process. Discover how Health Canada's CTA process compares.
Blog
Four Key Steps to Optimizing a Large Molecule Bioanalytical Program
Learn how Altasciences advances your biologic drug development with robust bioanalytical support. Expertise in large molecule bioanalysis fosters program success.